pyrroles has been researched along with Blood Loss, Surgical in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Hidaka, Y; Imai, T; Inaba, T; Kagawa, T; Omae, K; Tanaka, S | 1 |
Choi, G; Kang, H; Kim, BJ; Kim, JG | 1 |
Beltran, L; Bycroft, J; Green, JS; Hussain, M; Nair, R; Peters, JL; Powles, T; Shaw, GL | 1 |
1 review(s) available for pyrroles and Blood Loss, Surgical
Article | Year |
---|---|
Vonoprazan versus proton pump inhibitors for the management of gastric endoscopic submucosal dissection-induced artificial ulcer: A systematic review with meta-analysis.
Topics: Blood Loss, Surgical; Endoscopic Mucosal Resection; Humans; Proton Pump Inhibitors; Pyrroles; Randomized Controlled Trials as Topic; Sulfonamides; Treatment Outcome; Ulcer | 2019 |
1 trial(s) available for pyrroles and Blood Loss, Surgical
Article | Year |
---|---|
Efficacy of vonoprazan against bleeding from endoscopic submucosal dissection-induced gastric ulcers under antithrombotic medication: A cross-design synthesis of randomized and observational studies.
Topics: Aged; Aged, 80 and over; Blood Loss, Surgical; Cross-Sectional Studies; Endoscopic Mucosal Resection; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Male; Middle Aged; Pyrroles; Stomach Ulcer; Sulfonamides | 2021 |
1 other study(ies) available for pyrroles and Blood Loss, Surgical
Article | Year |
---|---|
Performing cytoreductive nephrectomy following targeted sunitinib therapy for metastatic renal cell carcinoma: a surgical perspective.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biopsy; Blood Loss, Surgical; Carcinoma, Renal Cell; Female; Humans; Indoles; Kidney Neoplasms; Length of Stay; London; Male; Middle Aged; Molecular Targeted Therapy; Neoadjuvant Therapy; Neoplasm Staging; Nephrectomy; Postoperative Complications; Pyrroles; Retrospective Studies; Risk Assessment; Risk Factors; Sunitinib; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2012 |